Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients.
P Langlade-Demoyen, … , F Ferchal, E Oksenhendler
P Langlade-Demoyen, … , F Ferchal, E Oksenhendler
Published March 1, 1994
Citation Information: J Clin Invest. 1994;93(3):1293-1297. https://doi.org/10.1172/JCI117085.
View: Text | PDF
Research Article Article has an altmetric score of 3

Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients.

  • Text
  • PDF
Abstract

Authors

P Langlade-Demoyen, N Ngo-Giang-Huong, F Ferchal, E Oksenhendler

×

Total citations by year

Year: 2019 2017 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1990 Total
Citations: 2 1 3 3 4 1 5 2 3 5 9 5 9 12 15 20 16 9 24 18 7 4 2 1 180
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (180)

Title and authors Publication Year
Large-Scale “OMICS” Studies to Explore the Physiopatholgy of HIV-1 Infection
SL Clerc, S Limou, JF Zagury
Frontiers in Genetics 2019
“Here Today, Gone Tomorrow” or “Here Today, Stay a Long While”: The Divergent Paths of Two Host Factors Important in Viral Infections
R Jhaveri
Clinical Therapeutics 2019
Evaluation of Different Parameters of Humoral and Cellular Immune Responses in HIV Serodiscordant Heterosexual Couples: Humoral Response Potentially Implicated in Modulating Transmission Rates
MJ Ruiz, J Salido, L Abusamra, Y Ghiglione, C Cevallos, G Damilano, AM Rodriguez, C Trifone, N Laufer, LD Giavedoni, O Sued, H Salomón, MM Gherardi, G Turk
EBioMedicine 2017
Immunogenetics: Genome-Wide Association of Non-Progressive HIV and Viral Load Control: HLA Genes and Beyond
S Limou, JF Zagury
Frontiers in immunology 2013
Functional Proteome of Macrophage Carried Nanoformulated Antiretroviral Therapy Demonstrates Enhanced Particle Carrying Capacity
AL Martinez-Skinner, RS Veerubhotla, H Liu, H Xiong, F Yu, JE McMillan, HE Gendelman
Journal of Proteome Research 2013
Vaccines
RW Sutter, OM Kew, SL Cochi, RB Aylward
Human vaccines 2013
Are Some People Protected Against HIV Infection?
M Clerici, M Biasin, GM Shearer
Models of Protection Against HIV/SIV 2012
The Immune System and Resisting HIV Infection
KR Fowke, CM Card, R Kaul
Models of Protection Against HIV/SIV 2012
The High Frequency of HIV Type 1-Specific Cellular Immune Responses in Seronegative Individuals with Parenteral and/or Heterosexual HIV Type 1 Exposure
BV Murashev, OV Nazarenko, EB Akulova, AK Artemyeva, SV Verevochkin, AV Shaboltas, RV Skochilov, OV Toussova, AP Kozlov
AIDS Research and Human Retroviruses 2012
Advances in Immunology
E Pinaud, M Marquet, R Fiancette, S Péron, C Vincent-Fabert, Y Denizot, M Cogné
Advances in Immunology Volume 110 2011
The chemokine receptor CCR5 in the central nervous system
S Sorce, R Myburgh, KH Krause
Progress in Neurobiology 2011
Effect of multiple infection of cells on the evolutionary dynamics of HIV in vivo : implications for host adaptation mechanisms
D Wodarz, DN Levy
Experimental biology and medicine (Maywood, N.J.) 2011
Phylogenetic analysis consistent with a clinical history of sexual transmission of HIV-1 from a single donor reveals transmission of highly distinct variants.
English S, Katzourakis A, Bonsall D, Flanagan P, Duda A, Fidler S, Weber J, McClure M, Phillips R, Frater J
Retrovirology 2011
Prior mucosal exposure to heterologous cells alters the pathogenesis of cell-associated mucosal feline immunodeficiency virus challenge
SB Kumar, S Leavell, K Porter, BD Assogba, MJ Burkhard
Retrovirology 2010
Preinfection Human Immunodeficiency Virus (HIV)-Specific Cytotoxic T Lymphocytes Failed To Prevent HIV Type 1 Infection from Strains Genetically Unrelated to Viruses in Long-Term Exposed Partners
Y Liu, A Woodward, H Zhu, T Andrus, J McNevin, J Lee, JI Mullins, L Corey, MJ McElrath, T Zhu
Journal of virology 2009
MULTIPLE HIV-1 INFECTION OF CELLS AND THE EVOLUTIONARY DYNAMICS OF CYTOTOXIC T LYMPHOCYTE ESCAPE MUTANTS
D Wodarz, DN Levy
Evolution 2009
HIV inactivation by cross-linking of photo-labeled anti-retroviral compounds with HIV reverse transcriptase
S Colby-Germinario, A Rios, J Quesada, D Anderson, AL Goldstein, T Fossum, MA Wainberg
Vaccine 2009
HIV Protocols
VR Prasad, GV Kalpana
HIV Protocols 2009
Primary Occult Hepadnavirus Infection Induces Virus-Specific T-Cell and Aberrant Cytokine Responses in the Absence of Antiviral Antibody Reactivity in the Woodchuck Model of Hepatitis B Virus Infection
SA Gujar, TI Michalak
Journal of virology 2009
Different immunodominance of HIV-1-specific CTL epitopes among three subtypes of HLA-A∗26 associated with slow progression to AIDS
Y Kawashima, M Satoh, S Oka, T Shirasaka, M Takiguchi
Biochemical and Biophysical Research Communications 2008
Lentiviral Vectors Encoding Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Receptor Genes Efficiently Convert Peripheral Blood CD8 T Lymphocytes into Cytotoxic T Lymphocytes with Potent In Vitro and In Vivo HIV-1-Specific Inhibitory Activity
A Joseph, JH Zheng, A Follenzi, T DiLorenzo, K Sango, J Hyman, K Chen, A Piechocka-Trocha, C Brander, E Hooijberg, DA Vignali, BD Walker, H Goldstein
Journal of virology 2008
A Single-Nucleotide Synonymous Mutation in the gag Gene Controlling Human Immunodeficiency Virus Type 1 Virion Production
T Hamano, K Matsuo, Y Hibi, AF Victoriano, N Takahashi, Y Mabuchi, T Soji, S Irie, P Sawanpanyalert, H Yanai, T Hara, S Yamazaki, N Yamamoto, T Okamoto
Journal of virology 2007
Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women
T Hirbod, K Broliden
Journal of Internal Medicine 2007
HIV and the Pathogenesis of AIDS
JA Levy
2007
Understanding the "lucky few": The conundrum of HIV-exposed, seronegative individuals
BL Shacklett
Current HIV/AIDS Reports 2006
HIV-Specific Antibodies But Not T-Cell Responses Are Associated With Protection in Seronegative Partners of HIV-1-Infected Individuals in Cambodia
M Nguyen, P Pean, L Lopalco, J Nouhin, V Phoung, N Ly, P Vermisse, Y Henin, F Barré-Sinoussi, SE Burastero, JM Reynes, G Carcelain, G Pancino
JAIDS Journal of Acquired Immune Deficiency Syndromes 2006
Protective immunity against hepatitis C virus infection
LN Elliott, AR Lloyd, JB Ziegler, RA Ffrench
Immunology and Cell Biology 2006
Understanding the "lucky few": The conundrum of HIV-exposed, seronegative individuals
BL Shacklett
Current Infectious Disease Reports 2006
HIV VACCINES
AJ McMichael
Annual Review of Immunology 2006
Cross-Clade Conservation of HIV Type 1 Nef Immunodominant Regions Recognized by CD8+T Cells of HIV Type 1 CRF02_AG-Infected Ivorian (West Africa)
A Inwoley, P Recordon-Pinson, M Dupuis, J Gaston, M Genête, A Minga, F Letourneur, F Rouet, J Choppin, H Fleury, JG Guillet, M Andrieu
AIDS Research and Human Retroviruses 2005
Human immunodeficiency virus (HIV)-2-specific T lymphocyte proliferative responses in HIV-2-infected and in HIV-2-exposed but uninfected individuals in Guinea-Bissau
S Andersson, O Larsen, ZD Silva, H Linder, H Norrgren, F Dias, R Thorstensson, P Aaby, G Biberfeld
Clinical & Experimental Immunology 2005
Distinct patterns of HIV-specific memory T lymphocytes in HIV-exposed uninfected individuals and in HIV-infected patients
M Schenal, SL Caputo, F Fasano, F Vichi, M Saresella, P Pierotti, ML Villa, F Mazzotta, D Trabattoni, M Clerici
AIDS 2005
Induction of serum and mucosal FIV-specific immune responses by intranasal immunization with p24Gag
S Leavell, B Wright, L Scappino, J Sirriyah, C Chen, JD Clements, MJ Burkhard
Vaccine 2005
Genetic analysis of human immunodeficiency virus type 1nef in portugal: Subtyping, identification of mosaic genes, and amino acid sequence variability
R Parreira, E Pádua, J Piedade, T Venenno, MT Paixão, A Esteves
Journal of Medical Virology 2005
Global human genetics of HIV-1 infection and China
TF ZHU, TJ FENG, X XIAO, H WANG, BP ZHOU
Cell Research 2005
Identification and characterization of HIV-1-specific CD8+ T cell epitopes presented by HLA-A*2601
M Satoh, Y Takamiya, S Oka, K Tokunaga, M Takiguchi
Vaccine 2005
Evidence of HIV exposure and transient seroreactivity in archived HIV-negative severe hemophiliac sera
SA Tenenbaum, CA Morris, SS Alexander, HE McFerrin, RF Garry, CA Leissinger
Virology Journal 2005
Identification and Characterization of HIV-1 Epitopes Presented by HLA-A*2603: Comparison Between HIV-1 Epitopes Presented by A*2601 and A*2603
Y Kawashima, M Satoh, S Oka, M Takiguchi
Human Immunology 2005
Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy
G Borkow, Z Bentwich
Clinical microbiology reviews 2004
Human α Defensin in HIV-Exposed But Uninfected Individuals
D Trabattoni, SL Caputo, G Maffeis, F Vichi, M Biasin, P Pierotti, F Fasano, M Saresella, M Franchini, P Ferrante, F Mazzotta, M Clerici
JAIDS Journal of Acquired Immune Deficiency Syndromes 2004
Human immunodeficiency virus type 1 gag-specific mucosal immunity after oral immunization with papillomavirus pseudoviruses encoding gag
H Zhang, R Fayad, X Wang, D Quinn, L Qiao
Journal of virology 2004
AIDS in Asia
Y Lu, M Essex, E Stiefvater
2004
Cellular Immune Responses in Seronegative Sexual Contacts of Acute Hepatitis C Patients
SM Kamal, A Amin, M Madwar, CS Graham, Q He, AA Tawil, J Rasenack, T Nakano, B Robertson, A Ismail, MJ Koziel
Journal of virology 2004
Most highly exposed seronegative men lack HIV-1-specific, IFN-gamma-secreting T cells
F Hladik, A Desbien, J Lang, L Wang, Y Ding, S Holte, A Wilson, Y Xu, M Moerbe, S Schmechel, MJ McElrath
Journal of immunology (Baltimore, Md. : 1950) 2003
Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals
T Zhu, L Corey, Y Hwangbo, JM Lee, GH Learn, JI Mullins, MJ McElrath
Journal of virology 2003
Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men
SL Caputo, D Trabattoni, F Vichi, S Piconi, L Lopalco, ML Villa, F Mazzotta, M Clerici
AIDS 2003
CD4 cell and CD8 cell-mediated resistance to HIV-1 infection in exposed uninfected intravascular drug users in Vietnam
LX Truong, TT Luong, D Scott-Algara, P Versmisse, A David, D Perez-Bercoff, NV Nguyen, HK Tran, CT Cao, A Fontanet, JY Follézou, I Theodorou, F Barré-Sinoussi, G Pancino
AIDS 2003
Identification and Characterization of HLA-A*3303-Restricted, HIV Type 1 Pol- and Gag-Derived Cytotoxic T Cell Epitopes
MS Hossain, H Tomiyama, T Inagawa, S Ida, S Oka, M Takiguchi
AIDS Research and Human Retroviruses 2003
Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes
OO Yang, PT Sarkis, A Ali, JD Harlow, C Brander, SA Kalams, BD Walker
Journal of Experimental Medicine 2003
T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?
CM Posavad, A Wald, N Hosken, ML Huang, DM Koelle, RL Ashley, L Corey
Journal of immunology (Baltimore, Md. : 1950) 2003
Determinants of HIV-1 Mutational Escape From Cytotoxic T Lymphocytes
OO Yang, PT Sarkis, A Ali, JD Harlow, C Brander, SA Kalams, BD Walker
Journal of Experimental Medicine 2003
Impacts of Avidity and Specificity on the Antiviral Efficiency of HIV-1-Specific CTL
OO Yang, PT Sarkis, A Trocha, SA Kalams, RP Johnson, BD Walker
Journal of immunology (Baltimore, Md. : 1950) 2003
Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure
JH Skurnick, P Palumbo, A DeVico, BL Shacklett, FT Valentine, M Merges, R Kamin-Lewis, J Mestecky, T Denny, GK Lewis, J Lloyd, R Praschunus, A Baker, DF Nixon, S Stranford, R Gallo, SH Vermund, DB Louria
The Journal of Infectious Diseases 2002
Host Background Immunity and Human Immunodeficiency Virus Protective Vaccines, a Major Consideration for Vaccine Efficacy in Africa and in Developing Countries
G Borkow, Z Bentwich
Clinical and vaccine immunology : CVI 2002
Dendritic Cell Amplification of HIV Type 1-Specific CD8+T Cell Responses in Exposed, Seronegative Heterosexual Women
BL Shacklett, RE Means, M Larsson, DT Wilkens, TJ Beadle, MJ Merritt, N Bhardwaj, PE Palumbo, JH Skurnick, DB Louria, DF Nixon
AIDS Research and Human Retroviruses 2002
Applied Immunohistochemistry
M Wu, T Putti, T Bhuiya
Applied Immunohistochemistry 2002
Cytotoxic T-cell recognition of HIV-1 cross-clade and clade-specific epitopes in HIV-1-infected Thai and Japanese patients
K Fukada, H Tomiyama, C Wasi, T Matsuda, S Kusagawa, H Sato, S Oka, Y Takebe, M Takiguchi
AIDS 2002
Immunologic Profile of Highly Exposed Yet HIV Type 1-Seronegative Men
OO Yang, WJ Boscardin, J Matud, MA Hausner, LE Hultin, PM Hultin, R Shih, J Ferbas, FP Siegal, M Shodell, GM Shearer, E Grene, M Carrington, S O'Brien, CB Price, R Detels, BD Jamieson, JV Giorgi
AIDS Research and Human Retroviruses 2002
Plasmid Immunization Primes Unique DTH Responses to HIV-1MNEnvelope Epitopes as Compared to Recombinant Protein Vaccination
MA Chattergoon, HH Maguire, TM Robinson, E Serrano, JD Boyer, DB Weiner
Hybridoma and Hybridomics 2002
Potent, Persistent Cellular Immune Responses Elicited by Sequential Immunization of Rhesus Macaques with Ad5 Host Range Mutant Recombinants Encoding SIV Rev and SIV Nef
LJ Patterson, N Malkevitch, J Zhao, B Peng, M Robert-Guroff
DNA and Cell Biology 2002
Human Immunodeficiency Virus (HIV)–Specific Cellular Immune Responses in Newborns Exposed to HIV In Utero
L Kuhn, S Meddows‐Taylor, G Gray, C Tiemessen
Clinical Infectious Diseases 2002
Polymorphism of the Human Immunodeficiency Virus Type 1 in Brazil: Genetic Characterization of the nef Gene and Implications for Vaccine Design
ML Guimarães, AS Moreira, MG Morgado
Memórias do Instituto Oswaldo Cruz 2002
The Geohelminths: Ascaris, Trichuris and Hookworm
CV Holland, MW Kennedy
2002
Nef-Mediated Resistance of Human Immunodeficiency Virus Type 1 to Antiviral Cytotoxic T Lymphocytes
OO Yang, PT Nguyen, SA Kalams, T Dorfman, HG Göttlinger, S Stewart, IS Chen, S Threlkeld, BD Walker
Journal of virology 2002
Late seroconversion in HIV-1 "resistant" prostitutes despite pre-existing HIV-1 specific CD8+ responses: association with reduced HIV exposure
Rupert Kaul, Sarah L. Rowland-Jones, Joshua Kimani, Tao Dong, Hong-Bing Yang, Peter Kiama, Timothy Rostron, Ephantus Njagi, Job J. Bwayo, Kelly S. MacDonald, Andrew J. McMichael, Francis A. Plummer
Journal of Clinical Investigation 2001
A Novel Recombinant Adeno-Associated Virus Vaccine Induces a Long-Term Humoral Immune Response to Human Immunodeficiency Virus
KQ Xin, M Urabe, J Yang, K Nomiyama, H Mizukami, K Hamajima, H Nomiyama, T Saito, M Imai, J Monahan, K Okuda, K Ozawa, K Okuda
Human Gene Therapy 2001
Low or no antibody responses to human immunodeficiency virus type 1 Nef in infected carriers with subtype E, in contrast to subtype B that showed antibodies preferentially recognizing subtype-specific Nef epitopes
S Komoto, M Kinomoto, MS Ibrahim, Q Zhong, W Auwanit, PI Ayuthaya, T Otake, H Mori, I Oishi, T Kurosu, H Takahashi, T Mukai, K Ikuta
Vaccine 2001
DNA vaccination in mice using HIV-1 nef, rev and tat genes in self-replicating pBN-vector
M Tähtinen, M Strengell, A Collings, J Pitkänen, A Kjerrström, K Hakkarainen, P Peterson, B Kohleisen, B Wahren, A Ranki, M Ustav, K Krohn
Vaccine 2001
Stimulation of HIV gp120-Specific Cytolytic T Lymphocyte Responsesin Vitroandin VivoUsing a Detoxified Pertussis Toxin Vector
NH Carbonetti, RG Tuskan, GK Lewis
AIDS Research and Human Retroviruses 2001
Reduced HIV-stimulated T-helper cell reactivity in cord blood with short-course antiretroviral treatment for prevention of maternal-infant transmission
L Kuhn, S Meddows-Taylor, G Gray, D Trabattoni, M Clerici, GM Shearer, C Tiemessen
Clinical & Experimental Immunology 2001
Vaccines and Vaccination
IR Mackay, FS Rosen, G Ada
New England Journal of Medicine 2001
Mucosal Exposure to Subinfectious Doses of SIV Primes Gut-Associated Antibody-Secreting Cells and T Cells: Lack of Enhancement by Nonneutralizing Antibody
N Polyanskaya, LA Bergmeier, SA Sharpe, N Cook, S Leech, G Hall, M Dennis, P Haaft, J Heeney, F Manca, T Lehner, MP Cranage
Virology 2001
Immune defence against HIV-1 infection in HIV-1-exposed seronegative persons
SC Schmechel, N Russell, F Hladik, J Lang, A Wilson, R Ha, A Desbien, MJ McElrath
Immunology Letters 2001
Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers
K Broliden, J Hinkula, C Devito, P Kiama, J Kimani, D Trabbatoni, JJ Bwayo, M Clerici, F Plummer, R Kaul
Immunology Letters 2001
Deletion of N-terminal myristoylation site of HIV Nef abrogates both MHC-1 and CD4 down-regulation
B Peng, M Robert-Guroff
Immunology Letters 2001
T-helper cell responses to HIV envelope peptides in cord blood: protection against intrapartum and breast-feeding transmission:
L Kuhn, A Coutsoudis, D Moodley, D Trabattoni, N Mngqundaniso, GM Shearer, M Clerici, HM Coovadia, Z Stein
AIDS 2001
Human immunodeficiency virus-1 specific and natural cellular immunity in HIV seronegative subjects with multiple sexual exposures to virus
E Nicastri, L Ercoli, L Sarmati, G d'Ettorre, P Iudicone, P Massetti, V Vullo, M Andreoni
Journal of Medical Virology 2001
HIV-1 transmission and acute HIV-1 infection
P Hansasuta, SL Rowland-Jones
British Medical Bulletin 2001
Antibodies in Viral Infection
DR Burton
2001
Cytotoxic T Lymphocyte Responses to Human Immunodeficiency Virus: Control and Escape
AK Sewell, DA Price, A Oxenius, AD Kelleher, RE Phillips
Stem Cells 2000
Feline Immunodeficiency Virus Clade C Mucosal Transmission and Disease Courses
LA Obert, EA Hoover
AIDS Research and Human Retroviruses 2000
HIV-1-specific cellular immune responses among HIV-1-resistant sex workers
KR Fowke, R Kaul, KL Rosenthal, J Oyugi, J Kimani, WJ Rutherford, NJ Nagelkerke, TB Ball, JJ Bwayo, JN Simonsen, GM Shearer, FA Plummer
Immunology and Cell Biology 2000
Anti-Cell Antibodies in Exposed Seronegative Individuals with HIV Type 1-Neutralizing Activity
L Lopalco, C Pastori, A Cosma, SE Burastero, B Capiluppi, E Boeri, A Beretta, A Lazzarin, AG Siccardi
AIDS Research and Human Retroviruses 2000
Persistently HIV-1 seronegative Nairobi sex workers are susceptible to in vitro infection
D Bienzle, KS Macdonald, KF Copeland, JJ Bwayo, FA Plummer, KL Rosenthal
The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses 2000
Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection
F Cocchi, AL DeVico, R Yarchoan, R Redfield, F Cleghorn, WA Blattner, A Garzino-Demo, S Colombini-Hatch, D Margolis, RC Gallo
Proceedings of the National Academy of Sciences 2000
Risk and management of blood-borne infections in health care workers
EM Beltrami, IT Williams, CN Shapiro, ME Chamberland
Clinical microbiology reviews 2000
Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus
Y Endo, T Igarashi, Y Nishimura, C Buckler, A Buckler-White, R Plishka, DS Dimitrov, MA Martin
Journal of virology 2000
Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway
JT Qiu, B Liu, C Tian, GN Pavlakis, XF Yu
Journal of virology 2000
Cytotoxic T lymphocytes in Human Immunodeficiency Virus type-1 infection Important or impotent?
J Gamberg, M Grant
Clinical and Applied Immunology Reviews 2000
Human Immunodeficiency Virus Type 1 Nef Epitopes Recognized in HLA-A2 Transgenic Mice in Response to DNA and Peptide Immunization
JK Sandberg, AC Leandersson, C Devito, B Kohleisen, V Erfle, A Achour, M Levi, S Schwartz, K Kärre, B Wahren, J Hinkula
Virology 2000
CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro
L Lopalco, C Barassi, C Pastori, R Longhi, SE Burastero, G Tambussi, F Mazzotta, A Lazzarin, M Clerici, AG Siccardi
Journal of immunology (Baltimore, Md. : 1950) 2000
Protection Against Retroviruses Are Owing to a Different Form of Immunity: An RNA-Based Molecular Immunity Hypothesis
O Bagasra, M Amjad
Applied Immunohistochemistry & Molecular Morphology 2000
Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia:
L Dorrell, AJ Hessell, M Wang, H Whittle, S Sabally, S Rowland-Jones, DR Burton, PW Parren
AIDS 2000
Creating HIV-1 reverse transcriptase cytotoxic T lymphocyte target structures by HLA-A2 heavy chain modifications
CS Cruz, R Tan, SL Rowland-Jones, BH Barber
International Immunology 2000
8 Br-cAMP enhances both humoral and cell-mediated immune responses induced by an HIV-1 DNA vaccine
H Arai, KQ Xin, K Hamajima, Y Lu, S Watabe, T Takahashi, S Toda, K Okuda, I Kudoh, M Suzuki, K Okuda
Gene Therapy 2000
AIDS Pathogenesis
H Schuitemaker, F Miedema
2000
Inhibition of Human Immunodeficiency Virus Type 1 Replication in Primary CD4 + T Lymphocytes, Monocytes, and Dendritic Cells by Cytotoxic T Lymphocytes
ME Severino, NV Sipsas, PT Nguyen, SA Kalams, BD Walker, RP Johnson, OO Yang
Journal of virology 2000
HIV-1-Specific Mucosal CD8 + Lymphocyte Responses in the Cervix of HIV-1-Resistant Prostitutes in Nairobi
R Kaul, FA Plummer, J Kimani, T Dong, P Kiama, T Rostron, E Njagi, KS MacDonald, JJ Bwayo, AJ McMichael, SL Rowland-Jones
Journal of immunology (Baltimore, Md. : 1950) 2000
Nonstandard Peptide Binding Revealed by Crystal Structures of HLA-B*5101 Complexed with HIV Immunodominant Epitopes
K Maenaka, T Maenaka, H Tomiyama, M Takiguchi, DI Stuart, EY Jones
Journal of immunology (Baltimore, Md. : 1950) 2000
Vaccine strategies for infectious diseases
M Clerici, S Piconi, D Trabattoni
Expert Opinion on Investigational Drugs 1999
IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine
KQ Xin, K Hamajima, S Sasaki, T Tsuji, S Watabe, E Okada, K Okuda
Vaccine 1999
Sexual transmission of HIV: infectiousness and prevention
PL Vernazza, JJ Eron, SA Fiscus, MS Cohen
AIDS 1999
Functional and genetic integrity of the CD8 T-cell repertoire in advanced HIV infection
JC Gamberg, MI Bowmer, JC Trahey, CM Campbell, I Pardoe, MD Grant
AIDS 1999
HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers
R Kaul, D Trabattoni, JJ Bwayo, D Arienti, A Zagliani, FM Mwangi, C Kariuki, EN Ngugi, KS MacDonald, TB Ball, M Clerici, FA Plummer
AIDS 1999
Anti-CD4 Antibodies in Exposed Seronegative Adults and in Newborns of HIV Type 1-Seropositive Mothers: A Follow-up Study
L Lopalco, Z Magnani, C Confetti, M Brianza, A Saracco, G Ferraris, F Lillo, C Vegni, A Lazzarin, AG Siccardi, SE Burastero
AIDS Research and Human Retroviruses 1999
Partial Resistance to Infection by R5X4 Primary HIV Type 1 Isolates in an Exposed-Uninfected Individual Homozygous for CCR5 32-Base Pair Deletion
L Xiao, SH Weiss, SH Qari, D Rudolph, C Zhao, TN Denny, T Hodge, RB Lal
AIDS Research and Human Retroviruses 1999
Safety and Immunogenicity of a Live Recombinant Canarypox Virus Expressing HIV Type 1 gp120 MN tm/gag/protease LAI (ALVAC-HIV, vCP205) Followed by a p24E-V3 MN Synthetic Peptide (CLTB-36) Administered in Healthy Volunteers at Low Risk for HIV Infection
D Salmon-Ceron, JL Excler, L Finkielsztejn, B Autran, JC Gluckman, D Sicard, TJ Matthews, B Meignier, C Valentin, RE Habib, C Blondeau, M Raux, C Moog, J Tartaglia, P Chong, M Klein, B Milcamps, F Heshmati, S Plotkin, TA Group, LA de Sida
AIDS Research and Human Retroviruses 1999
Attempt to modify the immune response developed against FIV gp120 protein by preliminary FIV DNA injection
AM Cuisinier, A Meyer, B Chatrenet, AS Verdier, A Aubert
Vaccine 1999
Immunomodulatory effect of a plasmid expressing CD40 ligand on DNA vaccination against human immunodeficiency virus type-1
A Ihata, S Watabe, S Sasaki, A Shirai, J Fukushima, K Hamajima, J Inoue, K Okuda
Immunology 1999
Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response
SA Stranford, J Skurnick, D Louria, D Osmond, SY Chang, J Sninsky, G Ferrari, K Weinhold, C Lindquist, JA Levy
Proceedings of the National Academy of Sciences 1999
Evaluation of novel human immunodeficiency virus type 1 Gag DNA vaccines for protein expression in mammalian cells and induction of immune responses
JT Qiu, R Song, M Dettenhofer, C Tian, T August, BK Felber, GN Pavlakis, XF Yu
Journal of virology 1999
The effect of viruses on the ability to present antigens via the major histocompatibility complex
VB Peters, KE Sperber
Microbes and Infection 1999
Identification of multiple HIV-1 CTL epitopes presented by HLA-B∗5101 molecules
H Tomiyama, T Sakaguchi, K Miwa, S Oka, A Iwamoto, Y Kaneko, M Takiguchi
Human Immunology 1999
HIV and the New Viruses
S McAdam, F Gotch
HIV and the New Viruses 1999
Lack of infection in HIV-exposed individuals is associated with a strong CD8+ cell noncytotoxic anti-HIV response
SA Stranford, J Skurnick, D Louria, D Osmond, SY Chang, J Sninsky, G Ferrari, K Weinhold, C Lindquist, JA Levy
Proceedings of the National Academy of Sciences 1999
Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection
S McAdam, P Kaleebu, P Krausa, P Goulder, N French, B Collin, T Blanchard, J Whitworth, A McMichael, F Gotch
AIDS 1998
Characterization of T cell-expressed chimeric receptors with antibody-type specificity for the CD4 binding site of HIV-1 gp120
N Bitton, F Verrier, P Debré, G Gorochov
European Journal of Immunology 1998
HIV pathogenesis: mechanisms of susceptibility and disease progression
JN Simonsen, KR Fowke, KS MacDonald, FA Plummer
Current Opinion in Microbiology 1998
Cross-Clade Envelope Glycoprotein 160-Specific CD8+Cytotoxic T Lymphocyte Responses in Early HIV Type 1 Clade B Infection
SE Wilson, SL Pedersen, JC Kunich, VL Wilkins, DL Mann, GP Mazzara, J Tartaglia, CL Celum, HW Sheppard
AIDS Research and Human Retroviruses 1998
Human Immunodeficiency Virus Type 1 Infection of Antigen-Specific CD4 Cytotoxic T Lymphocytes
PA Robbins, GL Roderiquez, KW Peden, MA Norcross
AIDS Research and Human Retroviruses 1998
Selection of virus variants and emergence of virus escape mutants after immunization with an epitope vaccine
L Mortara, F Letourneur, H Gras-Masse, A Venet, JG Guillet, I Bourgault-Villada
Journal of virology 1998
HLA antigens associated with susceptibility/resistance to HIV-1 infection
C Rohowsky-Kochan, J Skurnick, D Molinaro, D Louria
Human Immunology 1998
Frequency of the Δccr5 deletion allele in the urban Brazilian population
GA Passos, VP Picanço
Immunology Letters 1998
CD8+ T lymphocyte-derived chemokines and other HIV-suppressive factors: mini-review
L Furci, S Polo, P Lusso
Journal of chemotherapy (Florence, Italy) 1998
HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals
S Mazzoli, D Trabaironi, SL Caputo, S Piconi, C Blé, F Meacci, S Ruzzante, A Salvi, F Semplici, R Longhi, ML Fusi, N Tofani, M Biasin, ML Villa, F Mazzotta, M Clerici
Nature Medicine 1997
The organization of human leucocyte antigen class I epitopes in HIV genome products: implications for HIV evolution and vaccine design
C Zhang, JL Cornette, JA Berzofsky, C DeLisi
Vaccine 1997
DNA vaccination followed by macromolecular multicomponent peptide vaccination against HIV-1 induces strong antigen-specific immunity
K Okuda, KQ Xin, T Tsuji, H Bukawa, S Tanaka, WC Koff, K Tani, K Okuda, K Honma, S Kawamoto, K Hamajima, J Fukushima
Vaccine 1997
HIV-Specific Cytotoxic T Lymphocytes in Persons Exposed Through Sexual Contact With HIV-Infected Patients
&NA;
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1997
Nontransmission of HIV
&NA;
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1997
Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen
T Tsuji, K Hamajima, N Ishii, I Aoki, J Fukushima, K Xin, S Kawamoto, S Sasaki, KI Matsunaga, Y Ishigatsubo, K Tani, T Okubo, K Okuda
European Journal of Immunology 1997
HIV Type 1 Vaccine-Induced Cytotoxic T Cell Responses: Potential Role in Vaccine Efficacy
GL Ada, MJ McELRATH
AIDS Research and Human Retroviruses 1997
Human Immunodeficiency Virus Type 1 Glycoprotein 120-Specific T Lymphocytes Provide Intermolecular Help for Anti-CD4 Autoantibody Production in Exposed Uninfected Subjects
L Furci, A Beretta, A Siccardi, A Lazzarin, C Confetti, Z Magnani, P Scarpellini, L Lopalco, SE Burastero
AIDS Research and Human Retroviruses 1997
Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development
H Cao, P Kanki, JL Sankalé, A Dieng-Sarr, GP Mazzara, SA Kalams, B Korber, S Mboup, BD Walker
Journal of virology 1997
Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells
OO Yang, AC Tran, SA Kalams, RP Johnson, MR Roberts, BD Walker
Proceedings of the National Academy of Sciences 1997
Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus
RP Johnson, RL Glickman, JQ Yang, A Kaur, JT Dion, MJ Mulligan, RC Desrosiers
Journal of virology 1997
Frequency of HLA allele-specific peptide motifs in HIV-1 proteins correlates with the allele's association with relative rates of disease progression after HIV-1 infection
GW Nelson, R Kaslow, DL Mann
Proceedings of the National Academy of Sciences 1997
Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele
L Furci, G Scarlatti, S Burastero, G Tambussi, C Colognesi, C Quillent, R Longhi, P Loverro, B Borgonovo, D Gaffi, E Carrow, M Malnati, P Lusso, AG Siccardi, A Lazzarin, A Beretta
Journal of Experimental Medicine 1997
Protection of human immunodeficiency virus type 2-exposed seronegative macaques from mucosal simian immunodeficiency virus transmission
P Putkonen, B Mäkitalo, D Böttiger, G Biberfeld, R Thorstensson
Journal of virology 1997
Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization
TW Tobery, RF Siliciano
Journal of Experimental Medicine 1997
Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms
OO Yang, SA Kalams, A Trocha, H Cao, A Luster, RP Johnson, BD Walker
Journal of virology 1997
HIV-1-specific cell-mediated immunity is enhanced by co-inoculation of TCA3 expression plasmid with DNA vaccine
T Tsuji, J Fukushima, K Hamajima, N Ishii, I Aoki, H Bukawa, Y Ishigatsubo, K Tani, T Okubo, ME Dorf, K Okuda
Immunology 1997
Antigen-driven C-C Chemokine-mediated HIV-1 Suppression by CD4+ T Cells from Exposed Uninfected Individuals Expressing the Wild-type CCR-5 Allele
L Furci, G Scarlatti, S Burastero, G Tambussi, C Colognesi, C Quillent, R Longhi, P Loverro, B Borgonovo, D Gaffi, E Carrow, M Malnati, P Lusso, AG Siccardi, A Lazzarin, A Beretta
Journal of Experimental Medicine 1997
Immune response to human immunodeficiency virus (HIV) in healthcare workers occupationally exposed to HIV-contaminated blood
LA Pinto, AL Landay, JA Berzofsky, HA Kessler, GM Shearer
The American Journal of Medicine 1997
Recombinant Human Immunodeficiency Pr55gagVirus-like Particles Presenting Chimeric Envelope Glycoproteins Induce Cytotoxic T-Cells and Neutralizing Antibodies
L Deml, R Schirmbeck, J Reimann, H Wolf, R Wagner
Virology 1997
CD8+ cell-mediated immune responses: Relation to disease resistance and susceptibility in lentivirus-infected primates
L Buijs, WM Bogers, JW Eichberg, JL Heeney
Journal of Medical Primatology 1997
Mechanisms of resistance to HIV infection
WA Paxton, RA Koup
Springer Seminars in Immunopathology 1997
Differential Susceptibility to HIV-GP120–Sensitized Apoptosis in CD4+ T-Cell Clones With Different T-Helper Phenotypes: Role of CD95/CD95L Interactions
P Accornero, M Radrizzani, D Delia, F Gerosa, R Kurrle, MP Colombo
Blood 1997
Safety of Autologous, Ex Vivo-Expanded Human Immunodeficiency Virus (HIV)-Specific Cytotoxic T-Lymphocyte Infusion in HIV-Infected Patients
J Lieberman, PR Skolnik, GR Parkerson, JA Fabry, B Landry, J Bethel, J Kagan
Blood 1997
AIDS and transfer factor: Myths, certainties and realities
D Viza
Biotherapy 1996
Induction of HIV-1 Nef-specific cytotoxic T lymphocytes by Nef-expressing DNA vaccine
Y Asakura, K Hamajima, J Fukushima, H Mohri, T Okubo, K Okuda
American Journal of Hematology 1996
Correlates of protection in HIV infection and the progression of HIV infection to AIDS
M Clerici, GM Shearer
Immunology Letters 1996
HIV-1-specific immunity in persistently seronegative individuals at high risk for HIV infection
A Beretta, L Furci, S Burastero, A Cosma, ME Dinelli, L Lopalco, CD Santis, G Tambussi, E Carrow, S Sabbatani, M Clerici, A Lazzarin, AG Siccardi
Immunology Letters 1996
Autoantibodies to CD4 in HIV Type 1-Exposed Seronegative Individuals
S Burastero, D Gaffi, L Lopalco, G Tambussi, B Borgonovo, CD Santis, C Abecasis, P Robbioni, A Gasparri, A Lazzarin, F Celada, A Siccardi, A Beretta
AIDS Research and Human Retroviruses 1996
Sequence Note: Sequences and Phylogenetic Analysis of thenefGene from Thai Subjects Harboring Subtype E HIV-1
AW Artenstein, PA Hegerich, C Beyrer, K Rungruengthanakit, NL Michael, C Natpratan
AIDS Research and Human Retroviruses 1996
Relative resistance to HIV–1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high–risk sexual exposures
WA Paxton, SR Martin, D Tse, TR O'Brien, J Skurnick, NL VanDevanter, N Padian, JF Braun, DP Kotler, SM Wolinsky, RA Koup
Nature Medicine 1996
Protective immunity to HIV-1 in SCID/beige mice reconstituted with peripheral blood lymphocytes of exposed but uninfected individuals
C Zhang, Y Cui, S Houston, LJ Chang
Proceedings of the National Academy of Sciences 1996
Detection of simian immunodeficiency virus (SIV)-specific CD8+ T cells in macaques protected from SIV challenge by prior SIV subunit vaccination
SJ Kent, SL Hu, L Corey, WR Morton, PD Greenberg
Journal of virology 1996
A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction
JA Beatty, BJ Willett, EA Gault, O Jarrett
Journal of virology 1996
Do cytotoxic T lymphocytes clear some HIV/SIV infections?
G Ada
Journal of Medical Primatology 1996
Mécanismes immunopathologiques de l'infection par le virus de l'immunodéficience humaine
JC Gluckman
La Revue de Médecine Interne 1996
Protective immunity against HIV infection: has nature done the experiment for us?
GM Shearer, M Clerici
Immunology Today 1996
Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya
KR Fowke, NJ Nagelkerke, J Kimani, JN Simonsen, AO Anzala, JJ Bwayo, KS MacDonald, EN Ngugi, FA Plummer
The Lancet 1996
Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
R Liu, W A Paxton, S Choe, D Ceradini, S R Martin, R Horuk, M E MacDonald, H Stuhlmann, R A Koup, N R Landau
Cell 1996
8.3 Prospects for a preventive HIV vaccine
SJ Kent, RL Clancy, GL Ada
The Medical Journal of Australia 1996
Symposium in Immunology V
MM Eibl, C Huber, HH Peter, U Wahn
1996
Toward an Understanding of the Correlates of Protective Immunity to HIV Infection
BF Haynes, G Pantaleo, AS Fauci
Science 1996
Cytotoxic and proliferative T cell responses in HIV-1-infected Macaca nemestrina
SJ Kent, L Corey, MB Agy, WR Morton, MJ McElrath, PD Greenberg
Journal of Clinical Investigation 1995
ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids
LA Pinto, J Sullivan, JA Berzofsky, M Clerici, HA Kessler, AL Landay, GM Shearer
Journal of Clinical Investigation 1995
HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women
S Rowland-Jones, J Sutton, K Ariyoshi, T Dong, F Gotch, S McAdam, D Whitby, S Sabally, A Gallimore, T Corrah, M Takiguchi, T Schultz, A McMichael, H Whittle
Nature Medicine 1995
CTL to HIV-1: Surrogates or sirens
BJ Mathieson
Nature Medicine 1995
Long-term survivors of HIV-1 infection
MR Klein, F Miedema
Trends in Microbiology 1995
The T Helper Cell Shift in AIDS: Significance for Pharmacotherapy
M Clerici, GM Shearer
Clinical immunotherapeutics 1995
Cell Activation and Apoptosis in HIV Infection
JM Andrieu, W Lu
1995
Immune responses to human immunodeficiency virus type 1 in exposed but uninfected individuals: protection or chance?
DJ Looney
Journal of Clinical Investigation 1994
Cellular immunity and a type 1 cytokine profile in protection against HIV infection and progression to AIDS
M Clerici, GM Shearer
Research in Immunology 1994
The Th1–Th2 hypothesis of HIV infection: new insights
M Clerici, GM Shearer
Immunology Today 1994
Cytokine Patterns During the Progression to AIDS
TR Mosmann
Science 1994
Immunopathogenesis of HIV Infection
AS Fauci
Annals of the New York Academy of Sciences 1993
The Retroviridae
JA Levy
1993
Immunology of HIV Infection
DE Lewis, JV Giorgi
International Reviews of Immunology 1990

← Previous 1 2 3 … 7 8 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 clinical guideline sources
22 readers on Mendeley
See more details